FDA inspection
CTI Biopharma Corp: FDA inspection ending Nov 9, 2005
FDA inspection 403292 · No Action Indicated (NAI) · Seattle, WA
Key facts
| Inspection ID | 403292 |
|---|---|
| Firm | CTI Biopharma Corp |
| FEI number | 1000135672 |
| Address | 3101 Western Ave Ste 800 |
| City | Seattle |
| State | WA |
| ZIP | 98121-3017 |
| Fiscal year | 2006 |
| Inspection end date | Nov 9, 2005 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data